Shop Occupancy: Increased by 80 basis points sequentially. Shop Cash NOI Margin: 17.9% for the quarter. Senior Housing Triple Net Coverage: 1.36%. Skilled Occupancy: Increased by 60 basis points sequentially. Eitam Coverage: Reached an all-time high of 2.09. Normalized FFO per Share: $0.35 for the fourth quarter. Normalized AFFO per Share: $0.36 for the fourth quarter. Cash Rental Income: $90 million for the quarter. Cash NOI from Managed Senior Housing Portfolio: $24.1 million for the quarter. Recurring Cash G&A: $10.2 million for the quarter. Full Year Normalized FFO per Share: $1.39, representing 7% year-over-year growth. Full Year Normalized AFFO per Share: $1.44, representing 7% year-over-year growth. Net Debt to Adjusted EBITDA Ratio: 5.27 times as of December 31, 2024. Liquidity: $980 million as of December 31, 2024. Quarterly Cash Dividend: $0.30 per share, declared on February 3, 2025. Warning! GuruFocus has detected 7 Warning Signs with SBRA. Release Date: February 20, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Sabra Health Care REIT Inc (NASDAQ:SBRA) reported a 7% year-over-year growth in normalized AFFO, indicating strong financial performance. The senior housing and skilled nursing portfolios showed continued strength, with occupancy and margins improving. The company anticipates a higher volume of deals in 2025, suggesting potential growth opportunities. Cash NOI for the managed senior housing portfolio grew by 17.9% year-over-year, reflecting robust operational performance. Sabra Health Care REIT Inc (NASDAQ:SBRA) maintains a strong balance sheet with a net debt to adjusted EBITDA ratio of 5.27 times and ample liquidity of $980 million. Negative Points Workforce availability remains a challenge in the sector, although labor has stabilized. The political environment, particularly potential Medicaid cuts, poses a risk to the business. Cash rental income for the triple net portfolio decreased by $1.8 million due to timing of cash basis tenant rents and asset sales. Insurance costs increased significantly, although they represent less than 3% of total expenses. The company did not announce any new acquisitions this quarter, which may concern investors looking for immediate growth. Q & A Highlights Q: Looking ahead to 2025, what are your thoughts on the pacing of occupancy in the senior housing space? A: Talya Nevo-Hacohen, EVP, Chief Investment Officer, Treasurer, explained that operators are balancing rate increases versus occupancy. While Canadian portfolio growth is stabilizing, there is still room for occupancy growth in the domestic portfolio, particularly in Independent Living (IL) and Assisted Living (AL) sectors. Story Continues Q: Are you seeing any impacts in pricing for skilled nursing facilities (SNF) due to the current environment? A: Talya Nevo-Hacohen noted that the skilled nursing transaction market is robust, with strategic buyers valuing assets based on the revenue they generate for their entire business, leading to competitive pricing. Q: What has changed in the acquisition pipeline that makes you confident in accelerating deals this year? A: Richard Matros, CEO, stated that unlike last year, there is now higher deal volume and improved cost of capital, allowing Sabra to pursue more acquisitions. Talya Nevo-Hacohen added that there are many deals coming to market, driven by private equity firms exiting investments and refinancing opportunities due to interest rate changes. Q: Can you expand on the strategies operators have implemented to mitigate costs? A: Richard Matros highlighted that operators have embraced digital marketing for recruiting and revamped onboarding processes, including assigning mentors to new employees, which has helped improve employee retention and manage costs. Q: What are your thoughts on potential Medicare and Medicaid cuts and their impact? A: Richard Matros expressed that while any cuts are concerning, the bipartisan support and lobbying efforts, along with the strength of Sabra's portfolio, provide some confidence that the impact will be manageable. He noted that other programs like Medicaid expansion might be targeted first. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. View Comments
Sabra Health Care REIT Inc (SBRA) Q4 2024 Earnings Call Highlights: Strong Financial ...
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...